Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome
Teodor T. Postolache, Laura del Bosque‐Plata, Serge Jabbour, et al.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2019) Vol. 180, Iss. 3, pp. 186-203
Open Access | Times Cited: 99

Showing 26-50 of 99 citing articles:

Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
Antonio Vita, Sergio Barlati, Roberto Cavallaro, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort
Ellyn Dunbar, Phil J. Greer, Nadine Melhem, et al.
Journal of Gastroenterology (2020) Vol. 55, Iss. 10, pp. 1000-1009
Open Access | Times Cited: 27
Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
Silvana Galderisi, Marc D. Binder, Stefano Del Prato, et al.
European Psychiatry (2021) Vol. 64, Iss. 1
Open Access | Times Cited: 22
Association of metformin and depression in patients with type 2 diabetes
Huan Yu, Ruotong Yang, Junhui Wu, et al.
Journal of Affective Disorders (2022) Vol. 318, pp. 380-385
Closed Access | Times Cited: 15
Bidirectional association between physical multimorbidity and subclinical depression in Chinese older adults: Findings from a prospective cohort study
Bingqi Ye, Renxiang Xie, Shiva Raj Mishra, et al.
Journal of Affective Disorders (2021) Vol. 296, pp. 169-174
Closed Access | Times Cited: 19
Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
Xinyu Fang, Lingfang Yu, Dandan Wang, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 17
Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model
Chunhua Zhou, Dezhi Kong, Xiaodong Zhu, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 16
Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients
Xiaoe Lang, Yang Zhou, Lei Zhao, et al.
Psychoneuroendocrinology (2021) Vol. 132, pp. 105344-105344
Closed Access | Times Cited: 15
Prevalence and clinical correlates of thyroid dysfunction in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome
Quanfeng Zhu, Guojun Jiang, Xiaoe Lang, et al.
Journal of Affective Disorders (2023) Vol. 341, pp. 35-41
Closed Access | Times Cited: 6
Periodontal Pathogens and Neuropsychiatric Health
Abhishek Wadhawan, Mark A. Reynolds, Hina Makkar, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 15, pp. 1353-1397
Closed Access | Times Cited: 15
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation
Kateřina Horská, Hana Kotolová, Michal Karpíšek, et al.
Toxicology and Applied Pharmacology (2020) Vol. 406, pp. 115214-115214
Closed Access | Times Cited: 15
Smoking Affects the Patterns of Metabolic Disorders and Metabolic Syndrome in Patients With First-Episode Drug-Naive Schizophrenia: A Large Sample Study Based on the Chinese Han Population
Zezhi Li, Shuning Wang, Yuping Chen, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 24, Iss. 10, pp. 798-807
Open Access | Times Cited: 13
Associations between metabolic disorders and sleep disturbance in patients with schizophrenia
Huiming Yan, Zhenni Huang, Lu Yao, et al.
Comprehensive Psychiatry (2023) Vol. 122, pp. 152369-152369
Open Access | Times Cited: 5
Choroidal structural analysis in ultra-high risk and first-episode psychosis
Cemal Demirlek, Ferdane Ataş, Berna Yalınçetin, et al.
European Neuropsychopharmacology (2023) Vol. 70, pp. 72-80
Closed Access | Times Cited: 5
Electrophysiological correlates of visual backward masking in patients with major depressive disorder
Ophélie Favrod, Janir Nuno da Cruz, Maya Roinishvili, et al.
Psychiatry Research Neuroimaging (2019) Vol. 294, pp. 111004-111004
Open Access | Times Cited: 14
Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
Maria Giuseppina Petruzzelli, Lucia Marzulli, Orazio Valerio Giannico, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 13
Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
Yerye Gibrán Mayén-Lobo, José Jaime Martínez‐Magaña, Blanca Estela Pérez-Aldana, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 118-118
Open Access | Times Cited: 12
Neuroendocrine drivers of risk and resilience: The influence of metabolism & mitochondria
Susie Turkson, A. Kloster, Peter J. Hamilton, et al.
Frontiers in Neuroendocrinology (2019) Vol. 54, pp. 100770-100770
Open Access | Times Cited: 13
Shared Genetics of Psychiatric Disorders
Tova F Fuller, Victor I. Reus
F1000Research (2019) Vol. 8, pp. 1626-1626
Open Access | Times Cited: 13
Association between retinal vascular caliber and brain structure in schizophrenia
Vittal Korann, Abhishek Appaji, Arpitha Jacob, et al.
Asian Journal of Psychiatry (2021) Vol. 61, pp. 102707-102707
Open Access | Times Cited: 11
Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome
Mutaz Amin, Nicholas Horst, Rongling Wu, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Long-term safety and effectiveness of lurasidone in adolescents and young adults with schizophrenia: pooled post hoc analyses of two 12-month extension studies
Fabrizio Calisti, Michael Tocco, Yongcai Mao, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Metabolic syndrome patterns by gender in major depressive disorder
Li Lü, Ling Xiong, Zhihua Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0313629-e0313629
Open Access | Times Cited: 1
Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study
Tomasz Pawełczyk, Marta Grancow-Grabka, Natalia Żurner, et al.
Schizophrenia Research (2021) Vol. 230, pp. 61-68
Closed Access | Times Cited: 10
Primary care for individuals with serious mental illness (PriSMI): protocol for a convergent mixed methods study
Agnes Grudniewicz, Allie Peckham, David Rudoler, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e065084-e065084
Open Access | Times Cited: 7

Scroll to top